Dermira, Inc.
(NASDAQ : DERM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 4.03%69.701.0%$1071.78m
BIIBBiogen, Inc. 0.02%336.711.5%$665.47m
AMGNAmgen, Inc. 0.29%222.791.3%$550.81m
ILMNIllumina, Inc. -1.50%295.943.5%$414.21m
VRTXVertex Pharmaceuticals, Inc. 0.49%246.291.9%$346.37m
REGNRegeneron Pharmaceuticals, Inc. 1.01%403.152.6%$345.56m
ALXNAlexion Pharmaceuticals, Inc. 0.59%103.142.0%$220.13m
AAgilent Technologies, Inc. 0.85%85.061.6%$165.05m
EXASEXACT Sciences Corp. -2.59%99.9824.0%$144.57m
INCYIncyte Corp. -2.27%80.892.5%$113.92m
SGENSeattle Genetics, Inc. -1.12%117.006.1%$113.16m
BMRNBioMarin Pharmaceutical, Inc. 6.13%95.164.3%$102.95m
MRNAModerna, Inc. -1.67%18.230.0%$98.70m
XLRNAcceleron Pharma, Inc. -0.36%94.516.1%$91.83m
ALNYAlnylam Pharmaceuticals, Inc. -1.57%131.038.7%$91.49m

Company Profile

Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.